Skip to main content
. 2020 Sep 15;88(6):459–469. doi: 10.1016/j.biopsych.2020.03.010

Table 2.

Characteristics of the Study Population in the Adolescent Brain Cognitive Development (ABCD) Study

Baseline (n = 3515) Follow-up (n = 3076)
Age, Years 10.00 (± 0.61) 11.03 (± 0.63)
Sex, Male, n (%) 1851 (52.7%) 1610 (52.3%)
Puberty 1.56 (± 0.46) 1.79 (± 0.59)
BMI 18.59 (± 4.00) 19.45 (± 4.52)
Parental Education 17.01 (± 2.47) 17.16 (± 2.33)
Household Income 7.52 (± 2.19) 7.76 (± 2.06)
Race, n (%)
 White 2554 (72.7%) 2307 (75%)
 Black/African American 327 (9.3%) 244 (7.9%)
 Asian 182 (5.2%) 155 (5%)
 Other 452 (12.9%) 370 (12%)
Family Relationship, n (%)a
 Single 2680 (76.2%) 2346 (76.3%)
 Sibling 196 (5.6%) 166 (5.4%)
 Twin 630 (17.9%) 558 (18.1%)
 Triplet 9 (0.3%) 6 (0.2%)
ADHD Symptoms 2.54 (± 2.91) 2.36 (± 2.86)
ADHD Medication, n (%)
 No medication 3204 (91.2%) 2820 (91.7%)
 Stimulant only 233 (6.6%) 193 (6.3%)
 Nonstimulant only 31 (0.9%) 27 (0.9%)
 Stimulant + nonstimulant 46 (1.3%) 36 (1.2%)
Sleep Disturbance
 Total score 36.24 (± 7.87) 36.41 (± 7.75)
 Dyssomnia 22.19 (± 5.49) 22.66 (± 5.67)
 Parasomnia 14.05 (± 3.58) 13.75 (± 3.32)

Descriptive statistics are reported as mean (± SD) unless noted otherwise.

ADHD, attention-deficit/hyperactivity disorder; BMI, body mass index.

a

Provided by a questionnaire (“acspsw02”) from ABCD dataset.